James D. Talton

BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013.

Nanopharmaceutics, Inc. is a clinical-stage specialty pharmaceutical company that develops oral, topical, and injectable products for cancer, central nervous system disorders, and infectious diseases. The private company is based in Alachua, FL. The company leverages its expertise in nanoparticle and fine-particle formulations to improve hard-to-deliver biopharmaceutics classification system category II and IV drugs. Nanopharmaceutics is focused on formulation development aimed at improving drug absorption and stability. The company was founded by James D. Talton.

Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL.